SEC Form 4 · accession 0001171843-15-000486
TETRALOGIC PHARMACEUTICALS Corp · TLOG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Steinmetz
Director
Period of report
Jan 28, 2015
Accepted (ET)
Jan 30, 2015 · 3:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001361248
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $5.25 | Jan 28, 2015 | A | 10,000 | A | — | Jan 28, 2025 | Common Stock | 10,000 | 30,000 | D |
Explanation of responses
- F1Beginning January 28, 2015, stock options will vest and become exercisable over the following 12 months in equal increments. Stock options are subject to the reporting person's continued service as a director as of each vesting date.